Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Rising Tide Lifts Many Ships In Wake Of Eisai/Biogen’s Lecanemab Readout
Firms Boosted Regardless Of Alzheimer’s Drugs’ Mechanisms
Sep 28 2022
•
By
Mandy Jackson
Lilly and Roche, neck-and-neck with Eisai and Biogen, also rose on the Clarity AD data • Source: Shutterstock
More from Clinical Trials
More from R&D